NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

NANOVEU LIMITED (NVU)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of NVU: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000024796
Address: Level 5, 191 St Georges Terrace Perth Western Australia 6000
Tel:  +61 8 6244 9095

Date first listed: 30/11/2018

Sector: Technology Hardware & Equipment 
Activities: Technology company that shapes vision through the power of modern and cutting-edge nanotechnology. Nano imprint science is applied to deliver vision-based applications

News & Events

Expand this box to read and print

The suspension of trading in the securities of Nanovue Limited will be lifted from the commencement of trading on Wednesday, 10 April 2024 following lodgement of its annual report and release of an announcement regarding the outcome of the Company's application to the Supreme Court of Western Australia seeking orders in relation to the Company's inadvertent error to lodge a cleansing notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) in relation to the issue of 58,500,000 Shares on 27 January 2023.

09/04/2024

The company releases its Corporate Governance Statement.

04/04/2024

The company lodges an Appendix 4G.

04/04/2024

The company lodges its Annual Report to shareholders.

04/04/2024

There has been a delay in the lodgement of its Annual Report for the financial year ended 31 December 2023. The delay is to allow the Company's auditor, BDO Audit (WA) Pty Ltd, time to finalise itsreview. While the Company had anticipated that this would be finalised to allow for the release of its annual report by 28 March 2024, there have been delays resulting from unforeseen circumstances. The Company is in discussions with ASX regarding its financial position. Shareholders can expect those discussions to continue in the lead up to the Company releasing its Annual Report for FY2023 (expected in the week commencing 1 April 2024). Until those discussions have been resolved, the Company's securities will remain suspended from trading.

02/04/2024

The Company is in discussions with ASX regarding its financial position. Shareholders can expect those discussions to continue next week in the lead up to the Company releasing its Annual Report for FY23 (expected by 28 March 2024). Until those discussions have been resolved, the Company's securities will remain suspended from trading

22/03/2024

At the hearing earlier today, the Court made the orders sought by the Company, namely: that in relation to the Share Issues, pursuant to section 1322(4)(d) of the Corporations Act, the period of five business days referred to in section 708A(6)(a) of the Corporations Act be extended to 7 March 2024; that in relation to the Share Issues, pursuant to section 1322(4)(a) of the Corporations Act, it is declared that each notice under section 708A(5)(e) of the Corporations Act given to ASX on 7 March 2024 be deemed to take effect as if it had been given to ASX on the respective issue dates of the Share Issue; in relation to the shares issued on 27 January 2023 and 30 January 2023, pursuant to section 1322(4) of the Corporations Act, it is declared that any offer for sale or sale of those shares during the period after their respective issue to the date of the Court order is not invalid by reason of any failure of a notice under section 708A(5)(e) of the Corporations Act to exempt the sellers from the obligations of disclosure under the Corporations Act, and the seller's consequent failure to comply with section 707(3) of the Corporations Act; in relation to the Half Year Report, pursuant to section 1322 (4)(d) of the Corporations Act, the period by which the Half Year Report must be lodged with the ASIC referred to in section 320(1) of the Corporations Act be extended to 4 December 2023.

20/03/2024

The Company has made an application to the Supreme Court of Western Australia seeking orders in relation to: three inadvertent administrative errors whereby the Company failed to lodge a cleansing notice in strict compliance with the requirements of sections 708A(5)(e) of the Corporations Act 2001 (Cth) in connection with the issue of shares on 27 January 2023, 30 January 2023 and 20 June 2023; and its failure to lodge the 30 June 2023 half year report with the Australian Securities and Investments Commission by the date required in section 320(1) of the Corporations Act. The Application is scheduled to be heard by the Supreme Court of Western Australia at 11:00am on Tuesday 19 March 2024. The Company lodged its Half Year Report on 4 December 2023.

18/03/2024

The company releases an Appendix 2A.

07/03/2024

The company releases a cleansing notice.

07/03/2024

The company releases an Appendix 3G.

07/03/2024

The company releases a notification of cessation of securities.

07/03/2024

The company lodges its Preliminary Final Report.

29/02/2024

The company releases a notification regarding unquoted securities.

15/02/2024

The company releases a notice of application for quotation of securities.

01/02/2024

The company releases a notification regarding unquoted securities.

01/02/2024

The company releases a notice of application for quotation of securities.

31/01/2024

The company lodges its Quarterly Appendix 4C Cash Flow Report.

31/01/2024

The company lodges its Quarterly Activities Report.

31/01/2024

The company releases a notice of proposed issue of securities.

30/01/2024

The Company has received firm commitments from existing sophisticated and professional investors to raise $600,000 (before costs) through the placement of 35,294,117 fully paid ordinary shares in the Company at an issue price of $0.017 per Share, together with 1 free attaching unquoted option (exercisable at $0.025 expiring 36 months from the issue date of the Placement Share) for every 1 Placement Share issued. Nanoveu will repay an existing unsecured and interest free loan of $150,000 with Sixty Two via the issue Placement Shares and Placement Options on the same terms as the Placement. The Company will issue 8,823,529 Placement Shares and 8,823,529 Placement Options pursuant to the Company's placement capacity under ASX Listing Rule 7.1.

30/01/2024

The company lodges its Quarterly Activities Report.

04/12/2023

The company lodges its Quarterly Appendix 4C Cash Flow Report.

04/12/2023

The company lodges its Half Yearly Report and Accounts.

04/12/2023

Purchase orders received from Rahum Nanotech Co. Ltd for US$223,000 (AUD $350,110) to develop EyeFly3DTM products for the latest range of Smartphones. Purchase Order calls for Nanoveu to develop a universal base mould for imprinted lenses that can enable glasses-free 3D experiences on OLED based smartphones. Nanoveu to develop unique software (APP) and products that leverage Nanoveu's EyeFly3D technology to support the display of Rahum visual content in 3D without the need for glasses. Rahum's sales to target major phone brands like iPhone and Samsung, with plans to expand sales beyond South Korea.

06/11/2023

Nanoshield Solar boosted power output an average 25.4% compared to untreated solar panel controls over a 72 hour observation period. Results demonstrate tremendous potential of NanoshieldTM Solar range to increase power output efficiency, particularly for aged installations > 10 years old. Succesful demonstration expected to support US commercialisation efforts starting with the Southeast US solar markets.

01/11/2023

The company releases a response to the ASX Query.

04/08/2023

The company lodges its Quarterly Activities Report.

01/08/2023

The company lodges its Quarterly Appendix 4C Cash Flow Report.

01/08/2023

The securities of Nanoveu Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of NVU, pending the release of an announcement regarding the outcome of the Company's intended application to the Supreme Court of Western Australia seeking orders in relation to the Company's inadvertent error to lodge a cleansing notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) in relation to the issue of 58,500,000 Shares on 27 January 2023.

21/07/2023

The suspension of trading in the securities of Nanoveu Limited will be lifted from the commencement of trading on Friday, 14 August 2020, following the release by NVU of an announcement regarding a capital raising.

14/08/2020

The company releases a notice of Proposed issue of Securities - NVU.

14/08/2020

Nanoveu has secured an up to $2,400,000 investment by Antiviral Technologies Portfolio, LLC, a US based specialist institutional investor. An initial investment of $600,000 on execution. An additional $1,000,000 to be invested subject to shareholders' approval ($400,000 at the Investor's election). A further $800,000 may be invested by mutual consent of both parties subject to shareholders' approval. Funds will strengthen Nanoveu's balance sheet ahead of launch of new business lines including antiviral screen protector technology and laminating machines.

14/08/2020

The securities of Nanoveu Limited will be suspended from quotation from the commencement of normal trading on Friday, 7 August 2020 under Listing Rule 17.2, at the request of NVU, pending the release of an announcement regarding a capital raising.

06/08/2020

The suspension of trading in the securities of Nanoveu Limited will be lifted immediately following the release by NVU of an announcement regarding a new product.

15/04/2020

Nanoveu to incorporate antiviral nanotechnology into smartphone and tablet protective screens and cases, targeting late Q2 / early Q3 2020 product availability. Initial testing on the top layer of Nanoveu's planned products has demonstrated Nanoveu's technology to be effective against viruses and bacteria "“ including influenza A (subtype H3N2) and E. coli. Independent laboratories in the USA and Singapore have been engaged to conduct testing on prototypes for the human coronavirus OC43 (HCoV-OC43) (a betacoronavirus), which is the same genus as SARS-CoV-2 (the virus that causes COVID-19). Procurement for the first production run of smartphone protective screens is underway. Nanoveu's antiviral nanotechnology is considerably improved upon compared to existing anti-bacterial smartphone protective screens and cases which do not protect against viruses. Nanoveu is investigating pathways to market with potential for pre-orders in parallel with product development and production, targeting products being available in late Q2 2020 / early Q3 2020.

15/04/2020

The securities of Nanoveu Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of NVU, pending the release of an announcement regarding a new product..

07/04/2020

listed entity carried for record purposes only

03/12/2018

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    14/03/2023David Pevcic254,208$0.021$5,323
    14/11/2019Steven Apedaile80,000$0.054$4,300
    27/09/2019Steven Apedaile150,000$0.050$7,500
    19/09/2019Alfred Chong20,000$0.045$900
    04/06/2019Steven Apedaile100,000$0.071$7,100

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Alfred ChongExecutive Chairman, CEO30/11/2018
    David PevcicNon Exec Chairman03/02/2023
    Naomi HaydariCFO, Company Secretary20/06/2023
    Steven ApedaileNon Exec Director30/11/2018
    Michael WinloNon Exec Director28/03/2023

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Michael Van UffelenExecutive Director, CFO30/11/201830/06/2023
    Scott BeetonNon Exec Chairman23/09/202131/08/2022
    David NicolNon Exec Director30/11/201802/03/2022

    Date of first appointment, title may have changed.